Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ERYTECH Pharma S.A. Share Issue/Capital Change 2021

May 7, 2021

1295_dva_2021-05-07_057be2e4-2bf3-44d0-b8eb-b830628a0e84.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2021.

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France

Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com

Date Total of shares composing the
share capital
Total of brut (1) voting
rights
Total of net (2) voting rights
December 31, 2020 20
057
562
21 592
598
21 590
098
January 31, 2021 20
395 482
21
930 518
21
928
018
February 28, 2021 21 139 668 22 668 705 22 666 205
March 31, 2021 21 619 894 23 149 446 23 146 946
April 30, 2021 21 646 489 23 176 061 23 173 561

(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares.